Interventional Neurology Devices And Equipment Market Report 2026

Interventional Neurology Devices And Equipment Market Overview

• Interventional Neurology Devices And Equipment market size has reached to $2.45 billion in 2025 • Expected to grow to $3.72 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Surge In Neurological Disorders Drives Growth Of The Interventional Neurology Devices Market • Market Trend: Sentiva Duo Expands Treatment Options In The Interventional Neurology Devices And Equipment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interventional Neurology Devices And Equipment Market?

Interventional neurology devices are specialized instruments used in minimally invasive treatments for neurological conditions. They include tools such as stents, catheters, and coils, which help in procedures to treat brain aneurysms, stroke, and spinal disorders. The main types of interventional neurology devices and equipment are aneurysm coiling and embolization devices, cerebrospinal fluid management devices, neuro thrombectomy devices, and support devices. The neuro thrombectomy devices are used to perform mechanical thrombus removal from intracranial arteries angiographically. The aneurysm coiling and embolization devices types are embolic coils, flow diversion devices, and liquid embolic devices. The angioplasty devices types are carotid artery stents and embolic protection systems. The support devices types are micro guidewires and microcatheters. The neurothrombectomy device types are clot retrieval devices, suction and aspiration devices, and snares. The various end-users are hospitals, neurology clinics, ambulatory care centers, and others.

What Is The Interventional Neurology Devices And Equipment Market Growth Forecast?

The interventional neurology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.72 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising adoption of AI-supported neuroimaging, expansion of comprehensive stroke centers, growing focus on early intervention protocols, increasing investments in neurovascular innovation. Major trends in the forecast period include increasing adoption of neurothrombectomy devices, rising use of flow diversion and embolization technologies, growing integration of image-guided neurointerventions, expansion of minimally invasive stroke treatments, enhanced focus on rapid intervention outcomes.

Global Interventional Neurology Devices And Equipment Market Segmentation

1) By Product Type: Aneurysm Coiling And Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices 2) By Application: Stroke Management, Aneurysm Treatment, Arteriovenous Malformations (AVM) Treatment, Intracranial Stenosis, Other Neurovascular Disorders 3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers, Research & Academic Institutes Subsegments: 1) By Aneurysm Coiling And Embolization Devices: Flow Diverters, Embolic Coils, Liquid Embolics 2) By Cerebrospinal Fluid (CSF) Management Devices: CSF Shunts, CSF Drainage Systems 3) By Neurothrombectomy Devices: Clot Retrievers, Aspiration Devices, Snares 4) By Support Devices: Microcatheters, Guidewires

What Are The Drivers Of The Interventional Neurology Devices And Equipment Market?

Increase in the prevalence of neurological disorders cases is expected to drive the growth of the Interventional neurology devices market. Neural disorders such as Alzheimer's disease, cerebrovascular diseases including stroke, migraine, and other headache disorders are on the rise. The rapid increase in the geriatric population, high-stress levels in young individuals, and head injuries due to accidents are the main reasons for neural disorders. For instance, according to the Brain Aneurysm Foundation, a US-based organization for brain aneurysm awareness and education, it is estimated that in the United States, 6 million people suffer from unruptured brain aneurysms. Also, according to the World Health Organization, a US-based health organization, over 50 million people worldwide have epilepsy, and more than 47 million are affected by dementia. Therefore, increase in the prevalence of neurological disorders is going to propel the growth of the Interventional neurology devices market going forward. The rising demand for minimally invasive treatments is expected to propel the growth of the interventional neurology devices and equipment market going forward. Minimally invasive treatments refer to medical interventions that are performed with the aim of achieving a therapeutic or diagnostic outcome while causing minimal disruption to the body's tissues and structures. Minimally invasive procedures are becoming more popular in the treatment of neurological disorders through the use of interventional neurology devices, which are safer, more effective, and less disruptive options for patients. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, total surgical and non-surgical procedures increased by 3.4% in 2023, reaching 34.9 million. This growth was driven by a 5.5% rise in surgical procedures. Plastic surgeons performed over 15.8 million surgical procedures and 19.1 million non-surgical procedures, marking a 40% overall increase in procedures over the past four years. Therefore, the rising demand for minimally invasive treatments is driving the growth of the interventional neurology devices and equipment industry.

Key Players In The Global Interventional Neurology Devices And Equipment Market

Major companies operating in the interventional neurology devices and equipment market are Medtronic plc, Stryker Corporation, Terumo Corporation, Penumbra Inc., COVIDien, Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates, Bayer AG, MicroPort Scientific Corporation, Boston Scientific Corporation, Johnson & Johnson, Medikit Co. Ltd., Acandis GmbH, Biosensors International Ltd., Cook Group Incorporated, Siemens Healthineers, B. Braun Melsungen AG, Nihon Kohden Corporation, LivaNova, Teleflex Incorporated, Balt Extrusion SAS, Rapid Medical Ltd., phenox GmbH, Spiegelberg GmbH & Co. KG

Global Interventional Neurology Devices And Equipment Market Trends and Insights

Major companies operating in the interventional neurology devices and equipment market are developing innovative products such as SenTiva DUO to provide a new treatment option for patients with drug-resistant epilepsy who were previously unable to receive the latest VNS therapy. SenTiva DUO is a new implantable pulse generator (IPG) with a dual-pin header to provide vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy. For instance, in February 2023, LivaNova Plc., a UK-based medical device company, launched SenTiva DUO, a new implantable pulse generator (IPG) with a dual-pin header to provide vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy. It offers a new treatment option for patients with drug-resistant epilepsy who were previously unable to receive the latest VNS therapy. It also offers a number of advantages over the original SenTiva, including a smaller size, longer battery life, and compatibility with dual-pin leads.

Regional Outlook

North America was the largest region in the global interventional neurology devices and equipment market in 2025. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Interventional Neurology Devices And Equipment Market?

The interventional neurology devices and equipment market consists of sales of instruments such as carotid artery stents, embolic protection systems, micro guide wires, and micro catheters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.